公开(公告)号：EP1527083A1

公开(公告)日：2005-05-04

申请号：EP03740352.4

申请日：2003-06-26

申请人： Aventis Pharma Deutschland GmbH

发明人： BIGOT, Antony ,  STENGELIN, Siegfried ,  JÄHNE, Gerhard ,  HERLING, Andreas ,  MÜLLER, Günter ,  HOCK, Franz, Jakob ,  MYERS, Michael, R.

IPC分类号： C07H19/167 ,  A61K31/70

CPC分类号： C07H19/16

摘要： The present invention relates to compounds according to the general formula (I), wherein R1, A, B, Q, T, W and X have the meanings given in the description. These compounds are useful for the manufacture of a medicament for the treatment of insulin resistance, type 2 diabetes, metabolic syndrome, lipid disorders or cardiovasular disease or for providing an anti-lipolytic effect.